creatine has been researched along with Glycogen Storage Disease Type V in 14 studies
Glycogen Storage Disease Type V: Glycogenosis due to muscle phosphorylase deficiency. Characterized by painful cramps following sustained exercise.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Glycogen storage disease was suspected in a 10-month-old boy." | 7.68 | In vivo 13C-NMR evaluation of glycogen content in a patient with glycogen storage disease. ( Jehenson, P; Labrune, P; Odièvre, M; Syrota, A, 1992) |
| "Glycogen storage disease was suspected in a 10-month-old boy." | 3.68 | In vivo 13C-NMR evaluation of glycogen content in a patient with glycogen storage disease. ( Jehenson, P; Labrune, P; Odièvre, M; Syrota, A, 1992) |
| " An effective Cr dosage without adverse effects may be between 60 and 150 mg/kg daily." | 2.70 | Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle disease: double-blind, placebo-controlled crossover study. ( Fabian, K; Grehl, T; Hüsing, A; Jäger, M; Kley, R; Luttmann, A; Malin, JP; Mortier, W; Müller, K; Schröder, R; Vorgerd, M; Zange, J, 2002) |
| "Background McArdle disease (Glycogen Storage Disease type V) is caused by an absence of muscle phosphorylase leading to exercise intolerance,myoglobinuria rhabdomyolysis and acute renal failure." | 2.50 | Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V). ( Martinuzzi, A; Quinlivan, R; Schoser, B, 2014) |
| "McArdle disease (Glycogen Storage Disease type V) is caused by an absence of muscle phosphorylase leading to exercise intolerance, myoglobinuria rhabdomyolysis and acute renal failure." | 2.46 | Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V). ( Martinuzzi, A; Quinlivan, R; Schoser, B, 2010) |
| "Studies using the mdx model of Duchenne muscular dystrophy have found evidence of enhanced mitochondrial function, reduced intra-cellular calcium and improved performance with CrM supplementation." | 2.44 | Clinical use of creatine in neuromuscular and neurometabolic disorders. ( Tarnopolsky, MA, 2007) |
| "McArdle's disease is caused by genetic defects of the muscle-specific isozyme of glycogen phosphorylase, which block ATP formation from glycogen in skeletal muscle." | 2.44 | Treatment of glycogenosys type V (McArdle disease) with creatine and ketogenic diet with clinical scores and with 31P-MRS on working leg muscle. ( Vorgerd, M; Zange, J, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 9 (64.29) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Quinlivan, R | 2 |
| Martinuzzi, A | 2 |
| Schoser, B | 2 |
| Tarnopolsky, MA | 2 |
| Vorgerd, M | 5 |
| Quinlivan, RM | 1 |
| Beynon, RJ | 1 |
| Zange, J | 3 |
| Kley, RA | 1 |
| O'Sullivan, WJ | 1 |
| Haller, RG | 1 |
| Grehl, T | 2 |
| Jager, M | 2 |
| Muller, K | 2 |
| Freitag, G | 1 |
| Patzold, T | 1 |
| Bruns, N | 1 |
| Fabian, K | 2 |
| Tegenthoff, M | 1 |
| Mortier, W | 2 |
| Luttmann, A | 2 |
| Malin, JP | 2 |
| Haslinger, B | 1 |
| Küchle, C | 1 |
| Sitter, T | 1 |
| Held, E | 1 |
| Kley, R | 1 |
| Hüsing, A | 1 |
| Schröder, R | 1 |
| Labrune, P | 1 |
| Jehenson, P | 2 |
| Syrota, A | 2 |
| Odièvre, M | 1 |
| Duboc, D | 1 |
| Bloch, G | 1 |
| Fardeau, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Ketogenic Diet in McArdle Disease: a Multicentric Single Blind Controlled Trial[NCT04292938] | 16 participants (Actual) | Interventional | 2019-03-25 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for creatine and Glycogen Storage Disease Type V
| Article | Year |
|---|---|
Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V).
Topics: Creatine; Dietary Carbohydrates; Dietary Proteins; Dietary Supplements; Glycogen Storage Disease Typ | 2014 |
Clinical use of creatine in neuromuscular and neurometabolic disorders.
Topics: Animals; Body Composition; Charcot-Marie-Tooth Disease; Creatine; Disease Models, Animal; Glycogen S | 2007 |
Therapeutic options in other metabolic myopathies.
Topics: Animals; Carnitine O-Palmitoyltransferase; Creatine; Exercise Therapy; Glycogen Storage Disease; Gly | 2008 |
Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V).
Topics: Creatine; Dietary Carbohydrates; Dietary Proteins; Dietary Supplements; Glycogen Storage Disease Typ | 2010 |
Pharmacological and nutritional treatment trials in McArdle disease.
Topics: Creatine; Double-Blind Method; Glycogen Phosphorylase, Muscle Form; Glycogen Storage Disease Type V; | 2007 |
Treatment of glycogenosys type V (McArdle disease) with creatine and ketogenic diet with clinical scores and with 31P-MRS on working leg muscle.
Topics: Creatine; Dietary Supplements; Glycogen Storage Disease Type V; Humans; Muscle, Skeletal; Treatment | 2007 |
Creatine treatment in muscle disorders: a meta-analysis of randomised controlled trials.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Creatine; Dose-Response Relationship, Drug; Energy | 2008 |
2 trials available for creatine and Glycogen Storage Disease Type V
| Article | Year |
|---|---|
Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial.
Topics: Administration, Oral; Adult; Child; Creatine; Creatine Kinase; Cross-Over Studies; Double-Blind Meth | 2000 |
Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle disease: double-blind, placebo-controlled crossover study.
Topics: Adolescent; Adult; Child; Creatine; Cross-Over Studies; Double-Blind Method; Electromyography; Exerc | 2002 |
5 other studies available for creatine and Glycogen Storage Disease Type V
| Article | Year |
|---|---|
Nuclear magnetic resonance: this new diagnostic tool has direct clinical application.
Topics: Adenosine Triphosphate; Animals; Creatine; Dogs; Glycogen Storage Disease; Glycogen Storage Disease | 1981 |
Treatment of McArdle disease.
Topics: Creatine; Diet Therapy; Energy Metabolism; Exercise Tolerance; Glycogen Storage Disease Type V; Huma | 2000 |
[Acute renal failure due to rhabdomyolysis in McArdle's disease following binge drinking with seizures].
Topics: Acute Kidney Injury; Adult; Alcoholic Intoxication; Biopsy; Clinical Enzyme Tests; Creatine; Creatin | 2001 |
In vivo 13C-NMR evaluation of glycogen content in a patient with glycogen storage disease.
Topics: Creatine; Glycogen; Glycogen Storage Disease; Glycogen Storage Disease Type V; Humans; Infant; Liver | 1992 |
Diagnosis of muscular glycogenosis by in vivo natural abundance 13C NMR spectroscopy.
Topics: Adult; Creatine; Glycogen; Glycogen Storage Disease Type V; Humans; Magnetic Resonance Spectroscopy; | 1991 |